Abstract
Veliparib, a potent PARP inhibitor used against multiple cancerous cells such as metastatic melanoma, breast, non-small cell lung cancer (NSCLC) and p......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
